Skip to Main Content

Paper Details

A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy.
Cancer Immunology, Immunotherapy
14
2021
AKR1C2, BCR, CD4, COMP, CTLA4, EEF1A2, IRF5, IRGPS, LAG3, M2 macrophages, NTM, PCa, PDCD1, PPARGC1A, TIGIT, TIM3, TPX2, immune-related gene, immune-related gene-based prognostic signature, immune-related genes, patients, prostate cancer, regulatory T cells, resting mast cells, resting memory CD4 T cells, tumor
Author NameAffiliation
Xi ChenGuangzhou 12th People's Hospital
  • 1 - 1

Datasets

Release 1.2